Wellness Product Launches: Equelle For Menopause, Renadyl For Uremic Toxins, More
Executive Summary
S-equol in Equelle menopause supplement; antioxidant support for PTSD symptoms; supplement targets uremic toxins; green tea for heart health; and CartiJoint with Bio-Curcumin Curcugree.
You may also be interested in...
Research Bonafides, Detailing Gynecologists Included In Pharmavite's Third Women’s Health Line
“This acquisition, plus our existing women's health brands of Equelle and Uqora, positions us, the combined group, as the leader in women's health in nutraceuticals in the US,” says Pharmavite CEO Jeff Boutelle. Bonafide markets supplements for long-term, sustainable support for needs that compound with age, including hot flashes, vaginal dryness, vaginal microbiome and sexual satisfaction.
Pharmavite Moves Into OTCs With Uqora Acquisition To Expand Women’s Health Lineup
Pharmavite acquires Uqora, a startup marketing supplements, OTCs and devices to prevent or treat urinary tract infections. Moving into the category adds a growth driver as UTIs are the most common bacterial infection requiring medical care in the US.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.